Spots Global Cancer Trial Database for infigratinib
Every month we try and update this database with for infigratinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations | NCT04233567 | Advanced Malign... Cholangiocarcin... Metastatic Mali... Refractory Mali... | Infigratinib | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations | NCT05019794 | Gastric Cancer Gastroesophagea... Solid Tumor | Infigratinib | 18 Years - 75 Years | LianBio LLC | |
| Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations | NCT04233567 | Advanced Malign... Cholangiocarcin... Metastatic Mali... Refractory Mali... | Infigratinib | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification | NCT05510427 | Cholangiocarcin... Liver Cancer | Infigratinib Atezolizumab Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer | NCT04228042 | Renal Pelvis an... | Infigratinib Quality-of-Life... Questionnaire A... Surgical Proced... | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I BLASST-3 Trial | NCT04972253 | Bladder Transit... Bladder Cancer Fibroblast Grow... | Infigratinib | 18 Years - | Dana-Farber Cancer Institute | |
| Infigratinib in Recurrent High-Grade Glioma Patients | NCT04424966 | Glioma Glioblastoma GBM | Infigratinib | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations | NCT04233567 | Advanced Malign... Cholangiocarcin... Metastatic Mali... Refractory Mali... | Infigratinib | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Phase I BLASST-3 Trial | NCT04972253 | Bladder Transit... Bladder Cancer Fibroblast Grow... | Infigratinib | 18 Years - | Dana-Farber Cancer Institute | |
| Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations | NCT04197986 | Upper Tract Uro... Urothelial Blad... | Infigratinib Placebo | 18 Years - | QED Therapeutics, Inc. | |
| Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer | NCT04504331 | Breast Cancer HER2-negative B... ER Positive Bre... PR-Positive Bre... | Infigratinib Tamoxifen Omnipaque 350 Iopamidol Computed tomogr... | 18 Years - | Stanford University | |
| Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer | NCT04228042 | Renal Pelvis an... | Infigratinib Quality-of-Life... Questionnaire A... Surgical Proced... | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma | NCT06206278 | Gastric Cancer Gastroesophagea... | Infigratinib | 18 Years - 99 Years | LianBio LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
